JPMorgan Bullish on Givaudan, Expects Outperformance Relative to Peers

JPMorgan has added Givaudan stock to its list of positive catalysts ahead of the third-quarter earnings announcement on October 13, projecting organic sales growth of 6.7%—surpassing the consensus analyst estimate of approximately 5%.

The bank, which rates the stock "Overweight," believes that strong results could drive upward revisions to sales and earnings forecasts for 2026 and 2027, particularly as the company is expected to continue growing at a faster pace than its competitors in the ingredients sector.

JPMorgan also anticipates the operating profit margin rising to 24.1% in 2026—compared to the analyst estimate of 23.8%—and has raised its earnings-per-share forecasts to CHF 135.10 for 2026 and CHF 141.80 for 2027.

This optimistic outlook comes despite a roughly 3% decline in Givaudan’s share price since the bank's previous report; JPMorgan views this pullback as an opportunity, citing expectations for improved performance and the potential for the stock to command a higher valuation relative to its peers.